Home  |  Contact

UniProtKB/Swiss-Prot P43034: Variant p.Phe31Ser

Platelet-activating factor acetylhydrolase IB subunit beta
Gene: PAFAH1B1
Variant information

Variant position:  31
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Phenylalanine (F) to Serine (S) at position 31 (F31S, p.Phe31Ser).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from large size and aromatic (F) to small size and polar (S)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -2
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In LIS1.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.

Sequence information

Variant position:  31
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  410
The length of the canonical sequence.

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         LNRAIADYLRSNG-----------YEEAYSVFKKEAELDVNEELDKKY----------------AGLL

Chimpanzee                    LNRAIADYLRSNG-----------YEEAYSVFKKEAELDMN

Mouse                         LNRAIADYLRSNG-----------YEEAYSVFKKEAELDMN

Rat                           LNRAIADYLRSNG-----------YEEAYSVFKKEAELDMN

Pig                           LNRAIADYLRSNG-----------YEEAYSVFKKEAELDMN

Bovine                        LNRAIADYLRSNG-----------YEAAYSVFKKEAELDMN

Cat                           LNRAIADYLRSNG-----------YEEAYSVFKKEAELDMN

Chicken                       LNRAIADYLRSNG-----------YEEAYSVFKKEAELDVN

Xenopus laevis                LNRAIADYLRSNG-----------YEEAYSVFKKEAELDMN

Xenopus tropicalis            LNRAIADYLRSNG-----------YEEAYSVFKKEAELDMN

Caenorhabditis elegans        INRAIAEYMQNNG-----------YSESFSVFLKESSL---

Drosophila                    LNQAIADYLGSNG-----------YADSLETFRKEADL--S

Slime mold                    LNGSILDYFESSQ-----------YKSSFEEFKKETG----


Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

Chain 1 – 410 Platelet-activating factor acetylhydrolase IB subunit beta
Domain 7 – 39 LisH
Region 1 – 102 Interaction with NDEL1
Region 1 – 66 Interaction with NDE1
Region 1 – 38 Required for self-association and interaction with PAFAH1B2 and PAFAH1B3
Alternative sequence 12 – 64 Missing. In isoform 2.

Literature citations

LIS1 missense mutations cause milder lissencephaly phenotypes including a child with normal IQ.
Leventer R.J.; Cardoso C.; Ledbetter D.H.; Dobyns W.B.;
Neurology 57:416-422(2001)
Cited for: VARIANTS LIS1 SER-31; SER-162 AND HIS-317;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.